A group of clinicians and geochemists are working to develop a test for the most common form of primary liver cancer, HCC (Hepatocellular Carcinoma). HCC kills over 600,000 people worldwide every year. It usually develops ...
Aug 18, 2015
0
29
Researchers at the University of California, San Diego School of Medicine have demonstrated a direct connection between two signaling proteins and liver fibrosis, a scarring process underlying chronic liver disease, the 12th ...
Jul 29, 2015
0
19
Probiotics may improve the behavioral symptoms of chronic inflammatory diseases by altering communication between the immune system and the brain, according to an animal study published July 29 in the Journal of Neuroscience. ...
Jul 28, 2015
0
35
A rapid, sensitive, and accurate method to detect drug resistant hepatitis C virus (HCV) mutants has been developed. Researchers at Hiroshima University established a system to rapidly and accurately measure the presence ...
Jun 29, 2015
0
26
Researchers at University of California, San Diego School of Medicine and University College Dublin (UCD) have found that augmenting a naturally occurring molecule in the body can help protect against obesity-related diseases ...
Jun 8, 2015
0
78
Chronic liver diseases are steadily growing conditions, estimated to affect one in 10 Canadians. Most chronic liver diseases are "silent", attacking the liver for decades without symptoms until revealing themselves through ...
May 18, 2015
0
5
Hispanics in the United States face a higher risk than whites of dying from diabetes and liver disease, according to the first nationwide report of its kind released Tuesday by US health authorities.
May 5, 2015
0
11
A number of new, highly effective oral treatments for various types of hepatitis C have been approved in the past few years. However, two groups who have not benefitted from the new treatments are patients with hepatitis ...
Apr 30, 2015
0
45
Results presented today at The International Liver Congress 2015 show that the use of the fixed-dose combination of ledipasvir/sofosbuvir (LDV/SOF) in combination with ribavirin (RBV) was well tolerated and demonstrated high ...
Apr 23, 2015
0
6
In a recent study, Virginia Commonwealth University School of Medicine researchers predicted which cirrhosis patients would suffer inflammations and require hospitalization by analyzing their saliva, revealing a new target ...
Apr 17, 2015
0
8
